You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BRCA1

Showing 26 - 50 of 889
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2 Trial in Stockholm (Mifepristone)

Completed
  • Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2
  • Stockholm, Sweden
    Department of Woman and Child Health Karolinska University Hospi
Jan 15, 2022

Mesothelioma, Malignant Mesothelioma (MM), Early-stage Mesothelioma Trial run by the National Cancer Institute (NCI)

Not yet recruiting
  • Mesothelioma
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 1, 2023

Impact of Positive BRCA1/2 Mutation Status on Lives of Young

Completed
  • BRCA1 Gene
  • BRCA2 Gene
    • Bethesda, Maryland
      National Cancer Institute (NCI), 9000 Rockville Pike
    Nov 26, 2021

    Metastatic Castration-resistant Prostate Cancer Trial in Guangzhou (Pamiparib)

    Recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Apr 7, 2022

    BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Cancer Trial in Netherlands (Salpingectomy with delayed oophorectomy,

    Active, not recruiting
    • BRCA1 Gene Mutation
    • +2 more
    • Salpingectomy with delayed oophorectomy
    • Risk-reducing salpingo-oophorectomy
    • Maastricht, Limburg, Netherlands
    • +12 more
    May 17, 2022

    NSCLC Trial in Badalona, Málaga (Docetaxel, Cisplatin, Gemcitabine)

    Completed
    • Non-small Cell Lung Cancer
    • Badalona, Barcelona, Spain
    • +1 more
    Jun 8, 2022

    Genes Contributing to Hereditary Ovarian Cancer in Women and

    Completed
    • Ovarian Cancer
      • Seattle, Washington
        University of Washington
      Feb 2, 2022

      Breast Cancer Trial in France, Netherlands (ddAC-CP-Olaparib, ddAC-mini CTC)

      Recruiting
      • Breast Cancer
      • Marseille, France
      • +10 more
      Oct 11, 2022

      Early HER2-negative High-risk Breast Cancer and BRCA1/2

      Not yet recruiting
      • Breast Cancer
        • Arkhangelsk, Russian Federation
        • +19 more
        Jul 3, 2023

        Germline BRCA1 and BRCA2 Mutations in Jewish Women Affected by

        Completed
        • Breast Cancer
        • Blood test
        • Questionnaire
        • New York, New York
          Memorial Sloan Kettering Cancer Center
        Dec 27, 2021

        Identification of a Genetic Predisposition to ProstAte Cancer

        Active, not recruiting
        • Prostate Cancer in BRCA1 and BRCA2 Carriers
        • PSA test
        • Prostate Biopsy
        • Sutton, Surrey, United Kingdom
          Cancer Genetics Unit, Royal Marsden Hospital
        Mar 30, 2022

        Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

        Not yet recruiting
        • Metastatic Solid Tumor
        • +4 more
        • San Francisco, California
          University of California, San Francisco
        Jan 12, 2023

        Advanced Malignant Tumor, ATM Gene Mutation, BRCA1 Gene Mutation Trial in Houston (Laboratory Biomarker Analysis,

        Active, not recruiting
        • Advanced Malignant Neoplasm
        • +7 more
        • Laboratory Biomarker Analysis
        • +2 more
        • Houston, Texas
          M D Anderson Cancer Center
        Feb 21, 2022

        Breast Cancer After Ovarian Cancer During and/or After Therapy:

        Recruiting
        • BRCA-Associated Breast Carcinoma
        • Next-generation sequencing (NGS) assay TruSight Oncology 500 (TSO 500).
        • Rome, RM, Italy
          Fondazione Policlinico Universitario Agostino Gemelli IRCCS
        Mar 9, 2023

        Searching for Novel Germline Mutations in Lobular Breast Cancer

        Recruiting
        • Lobular Breast Carcinoma
        • +3 more
        • Illumina panel
        • Milan, Italy
          European Institute of Oncology
        Sep 12, 2022

        BRCA1 Hereditary Breast and Ovarian Cancer Syndrome Trial in Barretos (Doxorubicin, Carboplatin, Paclitaxel)

        Completed
        • BRCA1 Hereditary Breast and Ovarian Cancer Syndrome
        • Barretos, SP, Brazil
          Barretos Cancer Hospital
        Dec 25, 2022

        l, Laboratory and Epidemiologic Characterization of Individuals

        Completed
        • Familial Ovarian Cancer
        • +3 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Dec 31, 2022

          BRCA1 Mutation, BRCA2 Mutation Trial in New York, Durham, Houston (Family Letter (Standard of Care), Educational Video, Mailed

          Recruiting
          • BRCA1 Mutation
          • BRCA2 Mutation
          • Family Letter (Standard of Care)
          • +3 more
          • New York, New York
          • +2 more
          Aug 12, 2022

          Ovarian Tumors, BRCA1 Protein, BRCA2 Protein Trial in Worldwide (KU-0059436 (AZD2281)(PARP inhibitor))

          Active, not recruiting
          • Ovarian Neoplasms
          • +2 more
          • KU-0059436 (AZD2281)(PARP inhibitor)
          • Brussels, Belgium
          • +4 more
          Dec 19, 2022

          Advanced Breast Cancer Trial in Spain (Olaparib)

          Completed
          • Advanced Breast Cancer
          • Badalona, Barcelona, Spain
          • +15 more
          Jan 12, 2023

          Hereditary Breast and Ovarian Cancer Trial in Germany (Structured exercise training plus mediterranean diet)

          Recruiting
          • Hereditary Breast and Ovarian Cancer
          • Structured exercise training plus mediterranean diet
          • Berlin, Germany
          • +18 more
          Oct 25, 2022

          Molecular Profiling in Prostate Cancer

          Recruiting
          • Prostate Cancer Metastatic
          • +4 more
          • Tumor molecular profiling
          • Athens, Greece
            Hellenic Cooperative Oncology Group
          Mar 15, 2022

          Capturing BRCA1/2 Mutational Status in High Grade Serous Ovarian

          Active, not recruiting
          • Ovarian Cancer
          • BRCA genetic data
          • Toronto, Ontario, Canada
            Princess Margaret Cancer Centre
          Sep 29, 2021

          Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Adavosertib)

          Active, not recruiting
          • Advanced Lymphoma
          • +5 more
          • Philadelphia, Pennsylvania
            ECOG-ACRIN Cancer Research Group
          Jun 28, 2022

          TNBC - Triple-Negative Breast Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (olaparib, Durvalumab)

          Not yet recruiting
          • TNBC - Triple-Negative Breast Cancer
          • +2 more
          • (no location specified)
          Jan 12, 2022